Related references
Note: Only part of the references are listed.The effects of mGlu7 receptor modulation in behavioural models sensitive to antidepressant action in two mouse strains
Richard M. O'Connor et al.
BEHAVIOURAL PHARMACOLOGY (2013)
Interactions between antidepressants and P-glycoprotein at the blood-brain barrier: clinical significance of in vitro and in vivo findings
Fionn E. O'Brien et al.
BRITISH JOURNAL OF PHARMACOLOGY (2012)
Inhibition of P-glycoprotein enhances transport of imipramine across the blood-brain barrier: microdialysis studies in conscious freely moving rats
F. E. O'Brien et al.
BRITISH JOURNAL OF PHARMACOLOGY (2012)
ABCB1 polymorphism predicts escitalopram dose needed for remission in major depression
A. B. Singh et al.
TRANSLATIONAL PSYCHIATRY (2012)
Species Comparison of In Vivo P-Glycoprotein-Mediated Brain Efflux Using mdr1a-Deficient Rats and Mice
Christoffer Bundgaard et al.
DRUG METABOLISM AND DISPOSITION (2012)
Analytical procedures for the determination of the selective serotonin reuptake inhibitor antidepressant citalopram and its metabolites
Nora Unceta et al.
BIOMEDICAL CHROMATOGRAPHY (2011)
Failure to Replicate Genetic Associations with Antidepressant Treatment Response in Duloxetine-Treated Patients
Roy H. Perlis et al.
BIOLOGICAL PSYCHIATRY (2010)
Differences in the expression of endogenous efflux transporters in MDR1-transfected versus wildtype cell lines affect P-glycoprotein mediated drug transport
Konstantin Kuteykin-Teplyakov et al.
BRITISH JOURNAL OF PHARMACOLOGY (2010)
Involvement of NMDA receptors and L-arginine-nitric oxide-cyclic guanosine monophosphate pathway in the antidepressant-like effects of escitalopram in the forced swimming test
Andrea D. E. Zomkowski et al.
EUROPEAN NEUROPSYCHOPHARMACOLOGY (2010)
Blood-brain barrier penetration of the enantiomers of venlafaxine and its metabolites in mice lacking P-glycoprotein
Louise Karlsson et al.
EUROPEAN NEUROPSYCHOPHARMACOLOGY (2010)
MRP1 Polymorphisms Associated With Citalopram Response in Patients With Major Depression
Sung Hee Lee et al.
JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY (2010)
ABCB1 ( MDR1) polymorphisms and antidepressant response in geriatric depression
Jane E. Sarginson et al.
PHARMACOGENETICS AND GENOMICS (2010)
Species Differences in Blood-Brain Barrier Transport of Three Positron Emission Tomography Radioligands with Emphasis on P-Glycoprotein Transport
Stina Syvanen et al.
DRUG METABOLISM AND DISPOSITION (2009)
Polymorphisms in the drug transporter gene ABCB1 predict antidepressant treatment response in depression
Manfred Uhr et al.
NEURON (2008)
ABC multidrug transporters: structure, function and role in chemoresistance
Frances J. Sharom
PHARMACOGENOMICS (2008)
Citalopram enantiomers in plasma and cerebrospinal fluid of ABCB1 genotyped depressive patients and clinical response: A pilot study
Georg Nikisch et al.
PHARMACOLOGICAL RESEARCH (2008)
ABCB1 (MDR1) gene polymorphisms are associated with the clinical response to paroxetine in patients with major depressive disorder
Masaki Kato et al.
PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY (2008)
Differences in the transport of the antiepileptic drugs phenytoin, levetiracetarn and carbamazepine by human and mouse P-glycoprotein
Steffen Baltes et al.
NEUROPHARMACOLOGY (2007)
Blood-brain barrier penetration and pharmacokinetics of amitriptyline and its metabolites in p-glycoprotein (abcb1ab) knock-out mice and controls
Manfred Uhr et al.
JOURNAL OF PSYCHIATRIC RESEARCH (2007)
Kinetic analyses for species differences in P-glycoprotein-mediated drug transport
Miki Katoh et al.
JOURNAL OF PHARMACEUTICAL SCIENCES (2006)
ABCB1 (P-Glycoprotein/MDR1) gene G2677T/A sequence variation (polymorphism):: Lack of association with side effects and therapeutic response in depressed inpatients treated with amitriptyline
B Laika et al.
CLINICAL CHEMISTRY (2006)
Scientific perspectives on drug transporters and their role in drug interactions
Lei Zhang et al.
MOLECULAR PHARMACEUTICS (2006)
Functional assessment of multiple P-glycoprotein (P-gp) probe substrates: Influence of cell line and modulator concentration on P-GP activity
ME Taub et al.
DRUG METABOLISM AND DISPOSITION (2005)
Drug resistance in brain diseases and the role of drug efflux transporters
W Löscher et al.
NATURE REVIEWS NEUROSCIENCE (2005)
Cyclosporin A is a broad-spectrum multidrug. resistance modulator
M Qadir et al.
CLINICAL CANCER RESEARCH (2005)
Influence of P-glycoprotein inhibition on the distribution of the tricyclic antidepressant nortriptyline over the blood-brain barrier
TB Ejsing et al.
HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL (2005)
The tail suspension test as a model for assessing antidepressant activity: Review of pharmacological and genetic studies in mice
JF Cryan et al.
NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS (2005)
The impact of P-glycoprotein on the disposition of drugs targeted for indications of the central nervous system: Evaluation using the MDR1A/1B knockout mouse model
A Doran et al.
DRUG METABOLISM AND DISPOSITION (2005)
Paroxetine in major depression:: Correlating plasma concentrations and clinical response
C Normann et al.
PHARMACOPSYCHIATRY (2004)
Differential enhancement of antidepressant penetration into the brain in mice with abcb1ab (mdr1ab) P-glycoprotein gene disruption
M Uhr et al.
BIOLOGICAL PSYCHIATRY (2003)
Analysis of eighteen antidepressants, four atypical antipsychotics and active metabolites in serum by liquid chromatography:: a simple tool for therapeutic drug monitoring
C Frahnert et al.
JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES (2003)
abcblab P-glycoprotein is involved in the uptake of citalopram and trimipramine into the brain of mice
M Uhr et al.
JOURNAL OF PSYCHIATRIC RESEARCH (2003)
Comparison of in vitro P-glycoprotein screening assays: Recommendations for their use in drug discovery
D Schwab et al.
JOURNAL OF MEDICINAL CHEMISTRY (2003)
Are MDCK cells transfected with the Human MDR1 gene a good model of the human intestinal mucosa?
FX Tang et al.
PHARMACEUTICAL RESEARCH (2002)
Methodological issues in microdialysis sampling for pharmacokinetic studies
ECM de Lange et al.
ADVANCED DRUG DELIVERY REVIEWS (2000)
Penetration of amitriptyline, but not of fluoxetine, into brain is enhanced in mice with blood-brain barrier deficiency due to Mdr1a P-glycoprotein gene disruption
M Uhr et al.
NEUROPSYCHOPHARMACOLOGY (2000)
Share Paper
